Constrast-enhanced computed tomography radiomics predicts CD27 expression and clinical prognosis in head and neck squamous cell carcinoma

Objective This study aimed to construct a radiomics model that predicts the expression level of CD27 in patients with head and neck squamous cell carcinoma (HNSCC). Materials and methods Genomic data and contrast-enhanced computed tomography (CT) images of patients with HNSCC were downloaded from the Cancer Genome Atlas and Cancer Imaging Archive for prognosis analysis, image feature extraction, and model construction. We explored the potential molecular mechanisms underlying CD27 expression and its relationship with the immune microenvironment and predicted CD27 mRNA expression in HNSCC tissues. Using non-invasive, CT-based radiomics technology, we generated a radiomics model and evaluated its correlation with the related genes and HNSCC prognosis. Results and conclusion The expression level of CD27 in HNSCC may significantly influence the prognosis of patients with HNSCC. Radiomics based on contrast-enhanced CT is potentially effective in predicting the expression level of CD27.

[1]  A. Jimeno,et al.  Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors , 2022, Journal for ImmunoTherapy of Cancer.

[2]  J. Bae,et al.  Oral microbiome associated with lymph node metastasis in oral squamous cell carcinoma , 2021, Scientific Reports.

[3]  Xuefang Cao,et al.  Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation , 2021, Frontiers in Immunology.

[4]  G. Long,et al.  Immune checkpoint inhibitors in melanoma , 2021, The Lancet.

[5]  Á. Alberich-Bayarri,et al.  Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges. , 2021, Cancer treatment reviews.

[6]  W. Hofstetter,et al.  Esophageal Cancer: Tumor-Node-Metastasis Staging. , 2021, Radiologic clinics of North America.

[7]  Xiaofeng Tao,et al.  Machine learning–based MRI texture analysis to predict occult lymph node metastasis in early-stage oral tongue squamous cell carcinoma , 2021, European Radiology.

[8]  H. Kestler,et al.  Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC) , 2020, International journal of cancer.

[9]  I. Poon,et al.  Quantitative ultrasound radiomics in predicting recurrence for patients with node‐positive head‐neck squamous cell carcinoma treated with radical radiotherapy , 2020, Cancer medicine.

[10]  C. R. Leemans,et al.  Head and neck squamous cell carcinoma , 2020, Nature Reviews Disease Primers.

[11]  E. Engleman,et al.  Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance. , 2020, Annual review of pathology.

[12]  Jing Wang,et al.  Predicting lymph node metastasis in patients with oropharyngeal cancer by using a convolutional neural network with associated epistemic and aleatoric uncertainty , 2020, Physics in medicine and biology.

[13]  P. Schuler,et al.  Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy , 2020, Head & neck.

[14]  O. Taubmann,et al.  The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer , 2020, European Radiology.

[15]  Andrew J. Oler,et al.  Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency. , 2020, Blood.

[16]  Jie Cheng,et al.  Machine Learning Predicts Lymph Node Metastasis in Early-Stage Oral Tongue Squamous Cell Carcinoma. , 2020, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[17]  I. Flinn,et al.  Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies. , 2020, Blood advances.

[18]  Issam El Naqa,et al.  Machine and deep learning methods for radiomics. , 2020, Medical physics.

[19]  Boxin Zhang,et al.  Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy , 2020, Molecular therapy. Nucleic acids.

[20]  Georg Langs,et al.  Introduction to Radiomics , 2020, The Journal of Nuclear Medicine.

[21]  A. Berghoff,et al.  New emerging targets in cancer immunotherapy: CD27 (TNFRSF7) , 2020, ESMO Open.

[22]  anonymous,et al.  Comprehensive review , 2019 .

[23]  R. Ferris,et al.  The changing therapeutic landscape of head and neck cancer , 2019, Nature Reviews Clinical Oncology.

[24]  G. Zang,et al.  Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA , 2019, Drug design, development and therapy.

[25]  Ferran Reverter,et al.  SVM-RFE: selection and visualization of the most relevant features through non-linear kernels , 2018, BMC Bioinformatics.

[26]  T. So,et al.  Regulation of Interleukin-6 Receptor Signaling by TNF Receptor-Associated Factor 2 and 5 During Differentiation of Inflammatory CD4+ T Cells , 2018, Front. Immunol..

[27]  Ruud H. Brakenhoff,et al.  The molecular landscape of head and neck cancer , 2018, Nature Reviews Cancer.

[28]  N. Magné,et al.  Preclinical models in HNSCC: A comprehensive review. , 2017, Oral oncology.

[29]  Ho Yun Lee,et al.  Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications. , 2016, Diagnostic and interventional radiology.

[30]  H. Aerts,et al.  Applications and limitations of radiomics , 2016, Physics in medicine and biology.

[31]  H. Wajant.  Therapeutic targeting of CD70 and CD27 , 2016, Expert opinion on therapeutic targets.

[32]  N. Olsen,et al.  The CD27-CD70 pathway and pathogenesis of autoimmune disease. , 2016, Seminars in arthritis and rheumatism.

[33]  Dimitrios I. Fotiadis,et al.  Machine learning applications in cancer prognosis and prediction , 2014, Computational and structural biotechnology journal.

[34]  M. Moser,et al.  Role of CD27/CD70 pathway of activation in immunity and tolerance , 2011, Journal of leukocyte biology.

[35]  T. Takeuchi,et al.  Therapeutic targets of misguided T cells in systemic lupus erythematosus. , 2005, Current drug targets. Inflammation and allergy.